The at-home medical supplies provider CCS is expanding its business to better care for patients with chronic needs in the home.
Specifically, it is looking to transform the way diabetes patients are cared for in the home. To do so, CCS is expanding its patient education, monitoring and coaching services to “unify the patient experience.”
The Dallas-based CCS serves over 200,000 people across the country who are living with diabetes or other chronic conditions.
The medical device supplier now has two main divisions: CCS Medical and CCS Health.
CCS Health assists patients at home with their medical devices for disease management. CCS Medical is more in line with the company’s bread and butter. It offers patients advanced technology and products to monitor diabetes and other chronic conditions.
As a macro trend, the push towards at-home care — especially since the onset of the COVID-19 pandemic — has been good for CCS’ business. A second macro trend that CCS has made sure to stay on top of is the evolution and innovation of diabetes treatment and care.
Between those two trends, CCS has tried to bridge the gap in a “broken patient experience” when it comes to deploying the right kind of diabetes care, CCS CEO Tony Vahedian said.
“We’ve been doing this for 25 years, we’ve known diabetics forever and we have a highly trusted relationship with them,” Vahedian said.
CCS’ ability to address the two macro trends is conveniently “exactly what the patient needs,” he added. With a new focus on data and technology, CCS’ mission for the new model is to simplify the patient experience overall.
Too often, patients are discharged and left to fend and learn for themselves with medical devices when they are sent home, Vahedian said. CCS wants to change that.
“Once they get diagnosed, they can come to us and we can give them any device they want,” Vahedian said. “We can coach them on the device, refill the device and we can monitor them. It’s actually the most streamlined experience a patient can have, versus the fragmented one that they see today.”
CCS also has created a new strategic advisory board and added three board members, Francine Kaufman, Christos Cotsakos and Jean-Claude Saghbini.
“On the CCS Medical side, since we sit in the apex of all the relationships around that patient, Vahedian said. “The trick is to make sure that we have all the right relationships with all the right players to be able to service that patient the right way.”
Companies featured in this article:
